Navigation and Web Education for Colorectal Cancer

Recruiting at 1 trial location

Overseen By Ari Bell-Brown

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Fred Hutchinson Cancer Center

Disqualifiers: Non-english speakers, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 3

Duration: 3 months

75 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine the best way to help individuals treated for stage I-III colorectal cancer (CRC) maintain important post-treatment health checks. These checks are crucial for early detection of cancer recurrence. The study tests three approaches: patient navigation services, an interactive web education program called Current Together After Cancer (CTAC), or a combination of both. Individuals may qualify if they have undergone surgery for stage I-III CRC within the past three months and are receiving care at a participating clinic.

As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance post-treatment care for future patients.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these interventions are safe for colorectal cancer patients?

Previous studies have shown that patient navigation helps people maintain their colorectal cancer screenings, increasing the likelihood of following through with medical care. Research also indicates it can reduce healthcare costs while enhancing quality of life. No major safety concerns have been reported with patient navigation, which primarily assists patients in managing their care.

The web-based program, Current Together After Cancer (CTAC), is also under study. It aims to improve follow-up care for colorectal cancer survivors. Studies so far have not shown any direct risks from using CTAC. Designed as an educational tool, it guides patients in their post-treatment care.

Both approaches focus on helping patients manage their care after cancer treatment. No reports of harmful side effects have been linked to either method, suggesting they are well-tolerated by patients. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the trial for Navigation and Web Education for Colorectal Cancer because it aims to enhance post-surgery care through innovative support methods. Unlike the standard of care, which typically involves regular follow-ups and monitoring by healthcare providers, this trial explores new ways to empower patients. Arm A offers personalized navigation services, helping patients manage their care with reminders and scheduling assistance. Arm B introduces the CTAC online platform, providing interactive education and a convenient checklist for self-directed surveillance. Arm C combines both navigation and CTAC, offering a comprehensive approach to support patients in managing their post-surgical recovery more effectively. By testing these methods, researchers hope to improve patient outcomes and ease the burden of follow-up care.

What evidence suggests that this trial's treatments could be effective for improving surveillance in colorectal cancer patients?

Research shows that patient navigation services, which participants in Arm A of this trial will receive, effectively increase cancer screening rates. Studies have found that these services lead to more screenings and improved follow-up care. Additionally, patient navigation is linked to a better quality of life and lower costs in colorectal cancer care.

For the Current Together After Cancer (CTAC) online program, which participants in Arm B will access, early results suggest it improves follow-up care for colorectal cancer survivors. This program educates patients about their care needs and encourages adherence to check-up plans.

Participants in Arm C will receive both patient navigation services and access to the CTAC online program. Both strategies show promise in ensuring patients receive the recommended post-treatment check-ups. ^{1 2 4 6 7}

Who Is on the Research Team?

Rachel B. Issaka, MD, MAS

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Are You a Good Fit for This Trial?

This trial is for stage I-III colorectal cancer survivors who may not be following up with recommended surveillance care. It aims to see if navigation services, web education, or both can help improve their adherence to post-treatment check-ups and tests.

Inclusion Criteria

Being seen at a participating clinic

Ability to understand and complete surveys in English

I had surgery for stage I-III colon cancer within the last 3 months.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive navigation services, CTAC intervention, or both within 3 months of standard of care surgical resection for stage I-III CRC

3 months

In-person, telephone, or electronic conferencing platform

Follow-up

Participants are monitored for surveillance care completion and other outcomes

18 months

Follow-up at 3, 9, and 12-18 months post-surgical resection

What Are the Treatments Tested in This Trial?

Interventions

• Current Together After Cancer (CTAC)
• Patient Navigation

Trial Overview The study is testing the effectiveness of patient navigation services and an interactive web education program called Current Together After Cancer (CTAC) in increasing the rate at which colorectal cancer survivors undergo regular surveillance after treatment.

How Is the Trial Designed?

Group I: Arm C (navigation and CTAC) Experimental Treatment 5 Interventions

Patients at the Fred Hutch (Overlake) clinic location receive access to navigation services, in person, via telephone or via electronic conferencing platform, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, and access to the online CTAC intervention, which includes self-directed, interactive education about surveillance and a checklist of care, within 3 months of standard of care surgical resection.

Group II: Arm B (CTAC) Experimental Treatment 4 Interventions

Patients at the Fred Hutch (South Lake Union) clinic location receive access to the online CTAC intervention, which includes self-directed, interactive education about surveillance and a checklist of care, within 3 months of standard of care surgical resection.

Group III: Arm A (navigation) Experimental Treatment 3 Interventions

Patients at the Virginia Mason clinic location receive access to navigation services, in person, via telephone or via electronic conferencing platform, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, within 3 months of standard of care surgical resection.

Who Is Running the Clinical Trial?

Fred Hutchinson Cancer Center

Lead Sponsor

Trials

583

Recruited

1,341,000+

Citations

1. clinicaltrials.gov clinicaltrials.gov/study/NCT07018869

Study Details | NCT07018869 | Evaluating Whether an ... This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with ...

2. cancer.gov cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-03080

Evaluating Whether an Educational Website called Current ... This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with ...

3. centerwatch.com centerwatch.com/clinical-trials/listings/NCT07018869/evaluating-whether-an-educational-website-called-current-together-after-cancer-ctac-improves-follow-up-care-for-colorectal-cancer-survivors

Evaluating Whether an Educational Website Called ... This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of ...

4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC10526223/

Real-World Outcomes in Patients with Metastatic Colorectal ... Overall median overall survival (OS) was 26.72 months, and was longer in patients with left-sided tumors (28.85 vs. 21.04 months (right-sided ...

5. jamanetwork.com jamanetwork.com/journals/jamaoncology/fullarticle/2812113

Incidence of Recurrence and Time to Recurrence in Stage I ... For rectal cancer, the 5-year CIF decreased over the 3 periods from 19.9% to 9.5% for stage I, from 25.8% to 18.4% for stage II, and from 38.7% ...

6. ncbi.nlm.nih.gov ncbi.nlm.nih.gov/books/NBK618681/

Comparing Intensity of Follow-up Tests after Surgery for Colorectal ... Colorectal cancer (CRC) remains the third most common cancer in the United States. ... With the 5-year survival rate reaching 90% among patients with localized ...

7. asco.org asco.org/abstracts-presentations/ABSTRACT123196

Updated patient reported outcomes and survivorship care ... Overall, 63% reported chronic changes in bowel patterns, 38% chronic diarrhea, 9% bowel obstruction, 18% hernia development, 8% radiation colitis, and 2% ...